This site is intended for healthcare professionals only

Managing emerging toxicities
with novel treatments

in myeloma

Live
symposium
The 7th World Congress on Controversies in Multiple Myeloma (COMy 2021) Virtual Congress
Chaired by Mohamad Mohty
Featuring speakers: Saad Usmani, Noopur Raje, Luciano Costa, Marc Labetoulle

This independent symposium, led by a faculty comprising international key opinion leaders, aimed to give the target audience of hematologists, oncologists, oncology nurses, and healthcare professionals (HCPs) the necessary tools to identify and manage toxicity issues associated with new multiple myeloma treatments.

Learning objectives

After watching this recorded session, you will be able to:

  • Identify and explain toxicity issues related to new treatments for multiple myeloma
  • Debate how to appropriately manage multiple myeloma-related cardiovascular toxicities
  • Discuss and analyze the advances in the management of cytokine-release syndrome, neurotoxicities, and ocular toxicities, caused by novel treatments like CAR-T-cell therapy and antibody–drug conjugates
Program
Time Title Faculty
5 min
Welcome and introduction
Mohamad Mohty, France
15 min
Managing multiple myeloma-related cardiotoxicities
Saad Usmani, USA
15 min
Managing cytokine release syndrome after CAR-T cell therapy
Noopur Raj, USA
15 min
Managing neurotoxicities after CAR-T cells and T cell engagers
Luciano Costa, USA
15 min
Managing ocular adverse events after antibody drug-conjugates
Marc Labetoulle, France
20 min
Faculty discussion and audience questions
All, facilitated by Mohamad Mohty
5 min
Summary and conclusions
Mohamad Mohty, France
Faculty
Audience

This program is targeted at hematologists, oncologists, oncology nurses and healthcare professionals (HCPs) in Europe, USA, Canada and Japan.

Educational grant

This program is made possible thanks to an independent educational grant from GlaxoSmithKline.